[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 191,704,304
  • Shares Outstanding, K 539,708
  • Annual Sales, $ 36,751 M
  • Annual Income, $ 7,711 M
  • EBIT $ 10,568 M
  • EBITDA $ 16,935 M
  • 60-Month Beta 0.42
  • Price/Sales 5.20
  • Price/Cash Flow 10.47
  • Price/Book 20.79

Options Overview Details

View History
  • Implied Volatility 26.65% (+0.42%)
  • Historical Volatility 25.29%
  • IV Percentile 53%
  • IV Rank 45.54%
  • IV High 35.00% on 04/07/26
  • IV Low 19.66% on 08/15/25
  • Expected Move (DTE 3) 5.49 (1.54%)
  • Put/Call Vol Ratio 1.36
  • Today's Volume 5,315
  • Volume Avg (30-Day) 7,548
  • Put/Call OI Ratio 0.86
  • Today's Open Interest 129,679
  • Open Int (30-Day) 116,959
  • Expected Range 350.28 to 361.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 36 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $5.55
  • Number of Estimates 11
  • High Estimate $5.77
  • Low Estimate $5.30
  • Prior Year $6.02
  • Growth Rate Est. (year over year) -7.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
320.96 +10.16%
on 05/19/26
358.46 -1.36%
on 06/11/26
+27.28 (+8.36%)
since 05/15/26
3-Month
320.52 +10.32%
on 05/05/26
370.89 -4.66%
on 03/16/26
-12.62 (-3.45%)
since 03/13/26
52-Week
267.83 +32.02%
on 06/23/25
391.29 -9.63%
on 03/02/26
+58.37 (+19.77%)
since 06/13/25

Most Recent Stories

More News
How Is Biogen’s Stock Performance Compared to Other Biotech Stocks?

Biogen has recently outperformed its industry peers, and analysts remain reasonably upbeat about the stock’s prospects.

IBB : 171.51 (+0.50%)
AMGN : 352.79 (-0.68%)
BIIB : 198.00 (-1.02%)
2 S&P 500 Stocks with Competitive Advantages and 1 Facing Challenges

2 S&P 500 Stocks with Competitive Advantages and 1 Facing Challenges

COP : 112.62 (-3.73%)
HIG : 129.46 (-0.12%)
AMGN : 352.79 (-0.68%)
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

VESALIUS-CV Subgroup Results Show Repatha ® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk Diabetes

AMGN : 352.79 (-0.68%)
The Dow's Split Personality: Why Some Winners Soar While Others Drag Down the Dow

The oldest stock index in the world is suffering from a severe case of split personality. This internal friction has triggered a mechanical phenomenon, the likes of which I cannot recall, at least to...

NVDA : 212.21 (+3.42%)
AAPL : 295.45 (+1.48%)
$NASX : 26,653.19 (+2.95%)
CSCO : 120.83 (-0.22%)
CVX : 180.52 (-3.58%)
$SPX : 7,559.06 (+1.72%)
NKE : 45.19 (+0.58%)
GS : 1,080.68 (+1.69%)
AMGN : 352.79 (-0.68%)
MSFT : 399.40 (+2.22%)
CAT : 938.76 (+3.10%)
AXP : 337.61 (+3.74%)
How to Play QNT Stock After the Quantinuum IPO

Quantinuum’s IPO grabbed headlines, but its first trading day showed both excitement and caution. How can investors approach QNT stock after its Wall Street debut?

MITSY : 603.1500 (-0.14%)
EADSY : 53.1800 (+2.51%)
QNT : 59.92 (+8.43%)
HON : 230.09 (+4.44%)
JPM : 320.45 (-0.08%)
MIELY : 72.9250 (+4.06%)
BMWKY : 26.4156 (+2.19%)
AMGN : 352.79 (-0.68%)
Amgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies Conference

Amgen (NASDAQ:AMGN) executives used a Jefferies investor conference appearance to emphasize the company’s first-quarter growth, its late-stage pipeline and its preparations for potential launches, including...

AMGN : 352.79 (-0.68%)
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif. , June 4, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 47 th  Annual Global Healthcare Conference at 9:20 a.m. ET on Tuesday, June 9, 2026. Peter...

AMGN : 352.79 (-0.68%)
Honeywell Stock Is Likely to Reward Shareholders Following Quantinuum IPO, Split

HON will own a large stake in Quantinuum following the IPO.

EADSY : 53.1800 (+2.51%)
SNDK : 2,109.42 (+6.53%)
HON : 230.09 (+4.44%)
JPM : 320.45 (-0.08%)
ILMN : 164.45 (+2.16%)
WDC : 647.60 (+15.04%)
GRAL : 58.94 (-1.52%)
GEV : 979.63 (+4.14%)
BMWKY : 26.4156 (+2.19%)
AMGN : 352.79 (-0.68%)
GE : 345.08 (+2.92%)
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

New Phase 3 MITIGATE Open-Label Extension Data Support the Long-Term Safety Profile and Sustained Results of UPLIZNA ® in IgG4-RD

AMGN : 352.79 (-0.68%)
Dear Future Quantinuum Stock Investors, Mark Your Calendars for June 3

Investors may want to keep an eye on June 3 as Quantinuum is set to price its IPO and make a big move toward its Wall Street debut.

EADSY : 53.1800 (+2.51%)
HON : 230.09 (+4.44%)
JPM : 320.45 (-0.08%)
MS : 219.64 (+2.62%)
MIELY : 72.9250 (+4.06%)
BMWKY : 26.4156 (+2.19%)
AMGN : 352.79 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 364.46
2nd Resistance Point 361.31
1st Resistance Point 358.26
Last Price 352.79
1st Support Level 352.05
2nd Support Level 348.90
3rd Support Level 345.85

See More

52-Week High 391.29
Last Price 352.79
Fibonacci 61.8% 344.13
Fibonacci 50% 329.56
Fibonacci 38.2% 314.99
52-Week Low 267.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.